secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0001493152-23-003528
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte extends outside date for Razor Genomics sale to Feb 15, 2023
---------------------------------------------------------------------

- First Amendment extends closing deadline from Feb 1 to Feb 15, 2023 for sale of 70% of Razor Genomics to Dragon Scientific.
- Oncocyte will retain 30% equity interest in Razor after closing.
- No other terms of the original Stock Purchase Agreement were amended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223003528/0001493152-23-003528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223003528/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-003528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer